Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin Resistance Is Not Associated With Perceived Exertion or Cerebral Oxygenation During Exercise in Women.

Translational sports medicine·2026
Same author

Serum IgG1 and IgG3 Antibodies to Chlamydia trachomatis Pgp3 and Hsp60 in Men of Subfertile Couples.

The Journal of infectious diseases·2025
Same author

Serum IgG1 and IgG3 Antibody Responses to Chlamydia trachomatis Pgp3 and Hsp60 in Tubal Factor Infertility.

The Journal of infectious diseases·2025
Same author

Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial.

Breast cancer research and treatment·2024
Same author

Pregnancy and perinatal outcomes in women with recurrent pregnancy loss-A case-control study.

Acta obstetricia et gynecologica Scandinavica·2024
Same author

Genome-wide DNA methylation and gene expression in human placentas derived from assisted reproductive technology.

Communications medicine·2024

Related Experiment Video

Updated: Jun 16, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

[Menopause in a diabetic].

Lena Sjöberg-Tuominen1, Aila Tiitinen

  • 1Helsingin yliopisto, kliininen laitos, yleislääketieteen ja perusterveydenhuollon osasto.

Duodecim; Laaketieteellinen Aikakauskirja
|February 24, 2010
PubMed
Summary

Diabetic women, especially those with type 1 diabetes, face increased osteoporosis risk during menopause. Transdermal estrogen therapy can manage menopausal symptoms but requires careful assessment of cardiovascular risks and contraindications.

Area of Science:

  • Endocrinology
  • Menopause Studies
  • Bone Health

Background:

  • Rising incidence of type 1 and type 2 diabetes increases the number of menopausal diabetic women.
  • Type 1 diabetic patients exhibit a significant risk for osteoporosis.
  • Diabetic women experience menopausal symptoms similar to non-diabetic women.

Purpose of the Study:

  • To explore menopausal symptom management in diabetic women.
  • To evaluate the efficacy and safety of transdermal estrogen therapy for menopausal symptoms in diabetic women.
  • To highlight the importance of risk assessment before hormone therapy.

Main Methods:

  • Literature review on diabetes, menopause, osteoporosis, and hormone therapy.
  • Analysis of studies on transdermal estrogen administration.

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Related Experiment Videos

Last Updated: Jun 16, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

  • Emphasis on cardiovascular risk assessment and contraindication evaluation.

    • Main Results:

    • Transdermally administered estrogen is a favorable option for managing menopausal symptoms in diabetic women.
    • Osteoporosis risk is notably higher in type 1 diabetic patients.
    • Careful evaluation of contraindications and cardiovascular risk factors is crucial before initiating hormone therapy.

    Conclusions:

    • Transdermal estrogen therapy offers a viable treatment for menopausal symptoms in diabetic women.
    • Proactive management of osteoporosis and cardiovascular risks is essential for this population.
    • Individualized treatment plans considering patient-specific risks are recommended.